Last 12 months
Inside the activity.
4 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 4 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 13, 2020 Filed Jan 16, 2020 00:23 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 772 | $288.37 | $222,621.64 |
DisclosureSEC source: 0001209191-20-003555 · doc4.xml · nonDerivative · entry 7 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,382 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $288.19 to $288.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 13, 2020 Filed Jan 16, 2020 00:23 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 743 | $287.48 | $213,597.64 |
DisclosureSEC source: 0001209191-20-003555 · doc4.xml · nonDerivative · entry 6 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,154 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $287.00 to $287.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 13, 2020 Filed Jan 16, 2020 00:23 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 100 | $285.20 | $28,520.00 |
DisclosureSEC source: 0001209191-20-003555 · doc4.xml · nonDerivative · entry 5 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,897 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 13, 2020 Filed Jan 16, 2020 00:23 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 400 | $283.63 | $113,452.00 |
DisclosureSEC source: 0001209191-20-003555 · doc4.xml · nonDerivative · entry 4 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,997 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.30 to $283.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 13, 2020 Filed Jan 16, 2020 00:23 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 100 | $282.17 | $28,217.00 |
DisclosureSEC source: 0001209191-20-003555 · doc4.xml · nonDerivative · entry 3 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,397 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 13, 2020 Filed Jan 16, 2020 00:23 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 300 | $281.61 | $84,483.00 |
DisclosureSEC source: 0001209191-20-003555 · doc4.xml · nonDerivative · entry 2 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,497 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.01 to $281.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 13, 2020 Filed Jan 16, 2020 00:23 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
ConversionClass A Common Stock | 2,415 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-003555 · doc4.xml · nonDerivative · entry 1 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC |
WELLS DAVID BDirector
|
ConversionClass B Common Stock · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · derivative · entry 9 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. F8 · derivative.expiration_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC |
WELLS DAVID BDirector
|
Exercise / conversionClass B Common Stock · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · derivative · entry 8 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Class A Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. F8 · derivative.expiration_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC |
WELLS DAVID BDirector
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.36 | $0.00 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · derivative · entry 7 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Class B Common Stock · 10,000 shares Expires 2025-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option was granted on December 20, 2015, (the "Grant Date"). One-fourth (1/4th) of the shares subject to the option vest on the first anniversary of the Grant Date, with one forty-eighth (1/48th ) of the shares subject to the original grant vesting on each monthly anniversary thereafter, subject to continued service as a director of the Issuer through the applicable vesting dates. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC |
WELLS DAVID BDirector
|
SaleClass A Common Stock | 1,900 | $283.48 | $538,612.00 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · nonDerivative · entry 6 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,408 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $283.24 to $283.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC |
WELLS DAVID BDirector
|
SaleClass A Common Stock | 2,636 | $282.56 | $744,828.16 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · nonDerivative · entry 5 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,308 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $282.17 to $282.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC |
WELLS DAVID BDirector
|
SaleClass A Common Stock | 2,129 | $281.63 | $599,590.27 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · nonDerivative · entry 4 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,944 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.26 to $282.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC |
WELLS DAVID BDirector
|
SaleClass A Common Stock | 1,635 | $280.49 | $458,601.15 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · nonDerivative · entry 3 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,073 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $280.13 to $281.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC |
WELLS DAVID BDirector
|
SaleClass A Common Stock | 1,700 | $279.61 | $475,337.00 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · nonDerivative · entry 2 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,708 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $279.12 to $280.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 13, 2020 Filed Jan 15, 2020 23:42 UTC |
WELLS DAVID BDirector
|
ConversionClass A Common Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-003537 · doc4.xml · nonDerivative · entry 1 WELLS DAVID B · CIK 0001507645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
Exercise / conversionclass A Common Stock · Derivative | 2,716 | $0.00 Strike: $142.45 | $0.00 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · derivative · entry 14 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,819 Underlying: Class A Common Stock · 2,716 shares Expires 2028-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option was granted on December 1, 2018, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
Exercise / conversionClass A Common Stock · Derivative | 3,122 | $0.00 Strike: $48.00 | $0.00 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · derivative · entry 13 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,887 Underlying: Class A Common Stock · 3,122 shares Expires 2027-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option was granted on December 1, 2017, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest on each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 100 | $279.93 | $27,993.00 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · nonDerivative · entry 12 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,382 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 995 | $278.87 | $277,475.65 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · nonDerivative · entry 11 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,482 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $278.50 to $279.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 1,621 | $278.00 | $450,638.00 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · nonDerivative · entry 10 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,477 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $277.49 to $278.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
Exercise / conversionClass A Common Stock | 2,716 | $142.45 | $386,894.20 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · nonDerivative · entry 9 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 922 | $277.17 | $255,550.74 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · nonDerivative · entry 8 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,382 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.80 to $277.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 1,000 | $276.16 | $276,160.00 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · nonDerivative · entry 7 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,304 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.69 to $276.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 600 | $275.03 | $165,018.00 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · nonDerivative · entry 6 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,304 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.57 to $275.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 100 | $273.18 | $27,318.00 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · nonDerivative · entry 5 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,904 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 100 | $271.98 | $27,198.00 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · nonDerivative · entry 4 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,004 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 200 | $271.21 | $54,242.00 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · nonDerivative · entry 3 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,104 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.88 to $271.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
SaleClass A Common Stock | 200 | $266.44 | $53,288.00 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · nonDerivative · entry 2 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,304 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.01 to $266.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 21:17 UTC |
Stempeck Brian JohnDirector · Chief Strategy Officer
|
Exercise / conversionClass A Common Stock | 3,122 | $48.00 | $149,856.00 |
DisclosureSEC source: 0001209191-20-002511 · doc4.xml · nonDerivative · entry 1 Stempeck Brian John · CIK 0001671413 · Director · Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 365 | $0.00 Strike: $142.45 | $0.00 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · derivative · entry 14 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,790 Underlying: Class A Common Stock · 365 shares Expires 2028-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option was granted on December 1, 2018, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 875 | $0.00 Strike: $48.00 | $0.00 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · derivative · entry 13 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,137 Underlying: Class A Common Stock · 875 shares Expires 2027-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option was granted on December 1, 2017, the VCD. One forty-eighth (1/48) of the shares subject to the option vest each monthly anniversary of the VCD , subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 902 | $0.00 Strike: $30.15 | $0.00 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · derivative · entry 12 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,926 Underlying: Class A Common Stock · 902 shares Expires 2026-12-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option was granted on December 23, 2016. The VCD is December 1, 2016. One forty-eighth (1/48th) of the shares subject to the option vest each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
ConversionClass B Common Stock · Derivative | 1,263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · derivative · entry 11 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. F3 · derivative.expiration_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
Exercise / conversionClass B Common Stock · Derivative | 1,263 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · derivative · entry 10 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,263 Underlying: Class A Common Stock · 1,263 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. F3 · derivative.expiration_date: Each share of Class B Common Stock has no expiration date and is convertible for no additional consideration into one (1) share of Class A Common Stock at the option of the holder thereof at any time and upon certain other circumstances. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,263 | $0.00 Strike: $18.03 | $0.00 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · derivative · entry 9 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,136 Underlying: Class B Common Stock · 1,263 shares Expires 2026-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on August 15, 2016, the Vesting Commencement Date ("VCD"). One-fourth (1/4th) of the shares subject to the option vest on the first anniversary of the VCD, with one forty-eighth (1/48th) of the shares subject to the original grant vesting on each monthly anniversary thereafter, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
SaleClass A Common Stock | 365 | $263.52 | $96,184.80 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · nonDerivative · entry 8 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,735 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
Exercise / conversionClass A Common Stock | 365 | $142.45 | $51,994.25 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · nonDerivative · entry 7 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
SaleClass A Common Stock | 875 | $263.52 | $230,580.00 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · nonDerivative · entry 6 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,735 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
Exercise / conversionClass A Common Stock | 875 | $48.00 | $42,000.00 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · nonDerivative · entry 5 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
SaleClass A Common Stock | 902 | $263.52 | $237,695.04 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · nonDerivative · entry 4 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,735 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
Exercise / conversionClass A Common Stock | 902 | $30.15 | $27,195.30 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · nonDerivative · entry 3 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
SaleClass A Common Stock | 1,263 | $263.52 | $332,825.76 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · nonDerivative · entry 2 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,735 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:24 UTC |
Yang VivianChief Legal Officer
|
ConversionClass A Common Stock | 1,263 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-001812 · doc4.xml · nonDerivative · entry 1 Yang Vivian · CIK 0001615037 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:21 UTC |
VOBEJDA SUSANChief Marketing Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 365 | $0.00 Strike: $142.45 | $0.00 |
DisclosureSEC source: 0001209191-20-001789 · doc4.xml · derivative · entry 6 VOBEJDA SUSAN · CIK 0001755875 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,885 Underlying: Class A Common Stock · 365 shares Expires 2028-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option was granted on December 1, 2018, the VCD. One forty-eighth (1/48th) of the shares subject to the option vest each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:21 UTC |
VOBEJDA SUSANChief Marketing Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 875 | $0.00 Strike: $48.00 | $0.00 |
DisclosureSEC source: 0001209191-20-001789 · doc4.xml · derivative · entry 5 VOBEJDA SUSAN · CIK 0001755875 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,137 Underlying: Class A Common Stock · 875 shares Expires 2027-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on December 1, 2017, the Vesting Commencement Date ("VCD"). One forty-eighth (1/48th) of the shares subject to the option vest each monthly anniversary of the VCD, subject to continued employment with the Issuer through the applicable vesting dates. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:21 UTC |
VOBEJDA SUSANChief Marketing Officer
|
SaleClass A Common Stock | 365 | $263.52 | $96,184.80 |
DisclosureSEC source: 0001209191-20-001789 · doc4.xml · nonDerivative · entry 4 VOBEJDA SUSAN · CIK 0001755875 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,910 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:21 UTC |
VOBEJDA SUSANChief Marketing Officer
|
Exercise / conversionClass A Common Stock | 365 | $142.45 | $51,994.25 |
DisclosureSEC source: 0001209191-20-001789 · doc4.xml · nonDerivative · entry 3 VOBEJDA SUSAN · CIK 0001755875 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:21 UTC |
VOBEJDA SUSANChief Marketing Officer
|
SaleClass A Common Stock | 875 | $263.52 | $230,580.00 |
DisclosureSEC source: 0001209191-20-001789 · doc4.xml · nonDerivative · entry 2 VOBEJDA SUSAN · CIK 0001755875 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,910 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:21 UTC |
VOBEJDA SUSANChief Marketing Officer
|
Exercise / conversionClass A Common Stock | 875 | $48.00 | $42,000.00 |
DisclosureSEC source: 0001209191-20-001789 · doc4.xml · nonDerivative · entry 1 VOBEJDA SUSAN · CIK 0001755875 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.